within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10A_InsulinsAndAnalogues.A10AB05_InsulinAspart;
model InsulinAspart 
   extends Pharmacolibrary.Drugs.ATC.A.A10AB05;

  annotation(Documentation(
    info ="<html><body><p>Insulin aspart is a fast-acting insulin analog used in the treatment of diabetes mellitus type 1 and type 2 to improve glycemic control. It is a recombinant human insulin with an amino acid substitution that allows for more rapid absorption after subcutaneous injection. It is approved and widely used in current clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers following single subcutaneous injection of insulin aspart.</p><h4>References</h4><ol><li><p>Mathiesen, ER, Alibegovic, AC, Corcoy, R, Dunne, F, Feig, DS, Hod, M, Jia, T, Kalyanam, B, Kar, S, Kautzky-Willer, A, Marchesini, C, Rea, RD, &amp; Damm, P (2023). Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial. <i>The lancet. Diabetes &amp; endocrinology</i> 11(2) 86–95. DOI:<a href=&quot;https://doi.org/10.1016/S2213-8587(22)00307-2&quot;>10.1016/S2213-8587(22)00307-2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36623517/&quot;>https://pubmed.ncbi.nlm.nih.gov/36623517</a></p></li><li><p>Rasmussen, CH, Røge, RM, Ma, Z, Thomsen, M, Thorisdottir, RL, Chen, JW, Mosekilde, E, &amp; Colding-Jørgensen, M (2014). Insulin aspart pharmacokinetics: an assessment of its variability and underlying mechanisms. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 62 65–75. DOI:<a href=&quot;https://doi.org/10.1016/j.ejps.2014.05.010&quot;>10.1016/j.ejps.2014.05.010</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/24878388/&quot;>https://pubmed.ncbi.nlm.nih.gov/24878388</a></p></li><li><p>Rosinha, P, Teixeira, S, Vilaverde, J, &amp; Cardoso, MH (2022). Faster Insulin Aspart for Continuous Subcutaneous Insulin Infusion: Is It Worth It?. <i>Cureus</i> 14(8) e28422–None. DOI:<a href=&quot;https://doi.org/10.7759/cureus.28422&quot;>10.7759/cureus.28422</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36176818/&quot;>https://pubmed.ncbi.nlm.nih.gov/36176818</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end InsulinAspart;
